The cellular activity of cIAP1 and cIAP2 inhibitors was evaluated through experiments where cytotoxicity of a human prostate tumor cell line (PC-3) was assessed in the presence or absence of cytokines TNF and LT-α. The gene discussed is BIRC3; the disease is prostate neoplasm.